Katetrizačný uzáver uška ľavej prepresiene, v asn a neskor komplikácie /左心耳闭塞,早期和晚期并发症

Q4 Medicine
S. Mišíková, S. Juhás, D. Ondusova, M. Šimurda
{"title":"Katetrizačný uzáver uška ľavej prepresiene, v<e:1> asn<s:1> a neskor<e:1> komplikácie /左心耳闭塞,早期和晚期并发症","authors":"S. Mišíková, S. Juhás, D. Ondusova, M. Šimurda","doi":"10.4149/CARDIOL_2020_5_6_6","DOIUrl":null,"url":null,"abstract":"Objective: The aim of the observational, retrospective and single-centre study is to analyse early and late complications due to left atrial appendage occlusion with Amplatzer AmuletTM. Methods: We analyzed 49 patients (21 female and 28 male) with mean age of 72.1 ± 7.4 years. All patients were diagnosed with non-valvular atrial fibrillation and with high risk of thromboembolic (CHA2DS2-VASc 4,1 ± 1.3) and bleeding (HASBLED 3.3 ± 0.9) complications. We observed periprocedure, early (within 7 days after the procedure) and late complications: vascular, bleeding, stroke, systemic embolization, device embolization, pericardiac effusion and death. Results: The left atrial appendage was successfully managed in 47 (94.9%) patients. We observed one periprocedural complication – thrombus on the sheath. During follow-up 18.2 ± 17.7 month we observed one intracranial bleeding, one chronic pericardial effusion and 8 deaths. There was no connection between procedure and death in 5 patients, in 3 patients we were unable to determine the cause of death. Conclusion: Left atrial appendage occlusion is an effective and safe alternative to anticoagulation therapy in patients with nonvalvular atrial fibrillation and contraindication of anticoagulation therapy. The risk of complication is low thanks to correct selection of patients, strict compliance with the deployment rules and careful monitoring of patients. Fig. 3, Tab. 6. Ref. 39, on-line full text (Free, PDF) www.cardi-","PeriodicalId":38919,"journal":{"name":"Cardiology Letters","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Katetrizačný uzáver uška ľavej predsiene, včasné a neskoré komplikácie / Left atrial appendage occlusion, early and late complications\",\"authors\":\"S. Mišíková, S. Juhás, D. Ondusova, M. Šimurda\",\"doi\":\"10.4149/CARDIOL_2020_5_6_6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: The aim of the observational, retrospective and single-centre study is to analyse early and late complications due to left atrial appendage occlusion with Amplatzer AmuletTM. Methods: We analyzed 49 patients (21 female and 28 male) with mean age of 72.1 ± 7.4 years. All patients were diagnosed with non-valvular atrial fibrillation and with high risk of thromboembolic (CHA2DS2-VASc 4,1 ± 1.3) and bleeding (HASBLED 3.3 ± 0.9) complications. We observed periprocedure, early (within 7 days after the procedure) and late complications: vascular, bleeding, stroke, systemic embolization, device embolization, pericardiac effusion and death. Results: The left atrial appendage was successfully managed in 47 (94.9%) patients. We observed one periprocedural complication – thrombus on the sheath. During follow-up 18.2 ± 17.7 month we observed one intracranial bleeding, one chronic pericardial effusion and 8 deaths. There was no connection between procedure and death in 5 patients, in 3 patients we were unable to determine the cause of death. Conclusion: Left atrial appendage occlusion is an effective and safe alternative to anticoagulation therapy in patients with nonvalvular atrial fibrillation and contraindication of anticoagulation therapy. The risk of complication is low thanks to correct selection of patients, strict compliance with the deployment rules and careful monitoring of patients. Fig. 3, Tab. 6. Ref. 39, on-line full text (Free, PDF) www.cardi-\",\"PeriodicalId\":38919,\"journal\":{\"name\":\"Cardiology Letters\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiology Letters\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4149/CARDIOL_2020_5_6_6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiology Letters","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4149/CARDIOL_2020_5_6_6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

目的:观察、回顾性、单中心分析Amplatzer AmuletTM治疗左心耳闭塞的早期和晚期并发症。方法:49例患者,女性21例,男性28例,平均年龄72.1±7.4岁。所有患者均诊断为非瓣膜性房颤,并伴有血栓栓塞(CHA2DS2-VASc 4,1±1.3)和出血(HASBLED 3.3±0.9)并发症的高风险。我们观察了围手术期、早期(手术后7天内)和晚期并发症:血管、出血、中风、全身栓塞、器械栓塞、心包积液和死亡。结果:47例(94.9%)左心耳手术成功。我们观察到一例围手术期并发症-鞘上血栓。随访18.2±17.7个月,颅内出血1例,慢性心包积液1例,死亡8例。在5例患者中,手术与死亡之间没有联系,在3例患者中,我们无法确定死亡原因。结论:左心耳闭塞治疗非瓣膜性房颤是一种安全有效的抗凝治疗方法。由于正确选择患者,严格遵守部署规则和仔细监测患者,并发症的风险很低。图3,表6。参考文献39,在线全文(免费,PDF) www.cardi-
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Katetrizačný uzáver uška ľavej predsiene, včasné a neskoré komplikácie / Left atrial appendage occlusion, early and late complications
Objective: The aim of the observational, retrospective and single-centre study is to analyse early and late complications due to left atrial appendage occlusion with Amplatzer AmuletTM. Methods: We analyzed 49 patients (21 female and 28 male) with mean age of 72.1 ± 7.4 years. All patients were diagnosed with non-valvular atrial fibrillation and with high risk of thromboembolic (CHA2DS2-VASc 4,1 ± 1.3) and bleeding (HASBLED 3.3 ± 0.9) complications. We observed periprocedure, early (within 7 days after the procedure) and late complications: vascular, bleeding, stroke, systemic embolization, device embolization, pericardiac effusion and death. Results: The left atrial appendage was successfully managed in 47 (94.9%) patients. We observed one periprocedural complication – thrombus on the sheath. During follow-up 18.2 ± 17.7 month we observed one intracranial bleeding, one chronic pericardial effusion and 8 deaths. There was no connection between procedure and death in 5 patients, in 3 patients we were unable to determine the cause of death. Conclusion: Left atrial appendage occlusion is an effective and safe alternative to anticoagulation therapy in patients with nonvalvular atrial fibrillation and contraindication of anticoagulation therapy. The risk of complication is low thanks to correct selection of patients, strict compliance with the deployment rules and careful monitoring of patients. Fig. 3, Tab. 6. Ref. 39, on-line full text (Free, PDF) www.cardi-
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cardiology Letters
Cardiology Letters Medicine-Cardiology and Cardiovascular Medicine
CiteScore
0.20
自引率
0.00%
发文量
7
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信